XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 30.14

-3.3%

12:06 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (7692)	11/8/1998 9:56:00 PM
From: Bluegreen	Read Replies (1) of 17367

Does anyone see after reading the yahoo post the connection between possible meningitis, doing spinal taps and usage of Neuprex if approved? Now ask yourself how many spinal taps done per year in US alone. Is this just a niche market? If Neuprex is approved and only used possibly for gram neg infections only, is this also a niche market?<g> Admittedly still a big risk on Neuprex being approved but not thinking of utilization in real world by clinicians would be like not seeing clinicians prescribing Viagra to females BEFORE FDA indication. Like seen from the post from Yahoo, think REAL world.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next